Lu Ding
Impact in
- Virology top 1%
- HIV Research and Treatment
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Virology 16
- HIV Research and Treatment 16
-
- Multiple Myeloma Research and Treatments 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- Christopher J. Miller (14 shared papers)Michael B. McChesney (5 shared papers)Tracy Rourke (5 shared papers)Kristina Abel (4 shared papers)Marta L. Marthas (3 shared papers)Peter J. Dailey (3 shared papers)JUDITH TORTEN (2 shared papers)Kristen Bost (3 shared papers)
- Journals
- Journal of Virology (8 papers)Frontiers in Pharmacology (4 papers)Frontiers in Oncology (3 papers)AIDS Research and Human Retroviruses (3 papers)The Journal of Immunology (2 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lu Ding
55 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 99
- Virology 633
- Cancer Research 232
- Immunology 150
- Drug Discovery 2
- Pharmaceutical Science 43
Countries citing papers authored by Lu Ding
This map shows the geographic impact of Lu Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Ding more than expected).
Fields of papers citing papers by Lu Ding
This network shows the impact of papers produced by Lu Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Ding. The network helps show where Lu Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 138 | |
| 2 | 2002 | 119 | |
| 3 | 1998 | 117 | |
| 4 | 2020 | 114 | |
| 5 | 2003 | 97 | |
| 6 | 2001 | 85 | |
| 7 | 2001 | 80 | |
| 8 | 1998 | 78 | |
| 9 | 2014 | 77 | |
| 10 | 2001 | 59 | |
| 11 | 2016 | 58 | |
| 12 | 1998 | 55 | |
| 13 | 2020 | 55 | |
| 14 | 2004 | 52 | |
| 15 | 2020 | 51 | |
| 16 | 2008 | 50 | |
| 17 | 2018 | 48 | |
| 18 | 2008 | 39 | |
| 19 | 2020 | 35 | |
| 20 | 2019 | 34 |
About Lu Ding
Lu Ding is a scholar working on Virology, Hematology, Cancer Research, Molecular Biology and Hepatology, having authored 56 papers that have together received 1.9k indexed citations. Recurring topics across this work include HIV Research and Treatment (16 papers), Cancer-related molecular mechanisms research (5 papers), Multiple Myeloma Research and Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers), TGF-β signaling in diseases (2 papers), MicroRNA in disease regulation (2 papers) and Selenium in Biological Systems (2 papers). The work is most often cited by research in Virology (633 citations), Cancer Research (232 citations), Immunology (150 citations), Drug Discovery (2 citations) and Pharmaceutical Science (43 citations). Lu Ding has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Christopher J. Miller, Michael B. McChesney, Tracy Rourke, Kristina Abel, Marta L. Marthas, Peter J. Dailey, JUDITH TORTEN, Kristen Bost, Fuling Zhou and Linda Fritts. Their work appears in journals such as Journal of Virology, Frontiers in Pharmacology, Frontiers in Oncology, AIDS Research and Human Retroviruses and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.